Similar articles

• Clinical pharmacokinetics of digitalis glycosides.

  Doherty JE, de Soyza N, Kane JJ, Bissett JK, Murphy ML. Doherty JE, et al. Prog Cardiovasc Dis. 1978 Sep-Oct;21(2):141-58. doi: 10.1016/0033-0620(78)90020-8. Prog Cardiovasc Dis. 1978. PMID: 356122 Review. No abstract available.
• The capacity of different digitalis materials to induce ventricular rhythm disturbances in the reserpine-pretreated cat.

  Levitt B, Roberts J. Levitt B, et al. J Pharmacol Exp Ther. 1967 Apr;156(1):159-65. J Pharmacol Exp Ther. 1967. PMID: 6023592 No abstract available.
• Digitalis glycosides--recent advances in clinical pharmacology and treatment.

  Doherty JE, Kane JJ. Doherty JE, et al. South Med J. 1977 Apr;70(4):470-6. doi: 10.1097/00007611-197704000-00032. South Med J. 1977. PMID: 850814 No abstract available.
• A pharmacological approach to the mode of digitalis action.

  Godfraind T. Godfraind T. Verh K Vlaam Acad Geneeskd Belg. 1969;31(5):315-54. Verh K Vlaam Acad Geneeskd Belg. 1969. PMID: 4914642 Review. No abstract available.
• Myocardial contraction frequency and onset of cardiac glycoside action.

  Koch-Weser J. Koch-Weser J. Circ Res. 1971 Jan;28(1):34-48. doi: 10.1161/01.res.28.1.34. Circ Res. 1971. PMID: 5539438 No abstract available.